Anzeige
Mehr »
Freitag, 25.07.2025 - Börsentäglich über 12.000 News
Richtig investiert verwandelt der Goldpreis jeden Euro in glänzendes Vermögen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QRZ9 | ISIN: US45175G1085 | Ticker-Symbol:
NASDAQ
24.07.25 | 21:55
1,380 US-Dollar
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
IKENA ONCOLOGY INC Chart 1 Jahr
5-Tage-Chart
IKENA ONCOLOGY INC 5-Tage-Chart

Aktuelle News zur IKENA ONCOLOGY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
IKENA ONCOLOGY Aktie jetzt für 0€ handeln
DoIkena Oncology, Inc. - 10-Q, Quarterly Report 3
MiIkena Oncology stock rises after naming Kristin Yarema as CEO of combined company1
MiIkena Oncology, Inmagene Biopharmaceuticals appoint Kristin Yarema, as CEO1
MiIkena Oncology and Inmagene name Kristin Yarema as CEO of combined firm4
MiIkena Oncology, Inc.: Ikena Oncology and Inmagene Biopharmaceuticals Announce Kristin Yarema, Ph.D., as Chief Executive Officer of Merged Company131BOSTON and SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA) ("Ikena") and Inmagene Biopharmaceuticals ("Inmagene") today announced the appointment of Kristin Yarema...
► Artikel lesen
DiIkena Oncology, Inc. - 8-K, Current Report1
16.07.Ikena Oncology ändert Vergütungsvereinbarung für Dr. Jotin Marango vor Fusion1
15.07.Ikena Oncology, Inc.: Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals123Combined Company to Trade on Nasdaq Under Ticker "IMA" Ikena Announces 1-for-12 Reverse Stock Split of Ikena Common Stock BOSTON and SAN DIEGO, July 15, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc....
► Artikel lesen
12.07.ISS And Glass Lewis Support Ikena's Share Issuance For Proposed Inmagene Merger5
11.07.Ikena Oncology, Inc. - 8-K, Current Report1
11.07.Ikena Oncology, Inc.: Ikena Oncology Announces ISS and Glass Lewis Recommend Stockholders Vote "FOR" Proposed Merger with Inmagene Biopharmaceuticals77BOSTON, July 11, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA, "Ikena," the "Company") today announced that Institutional Shareholder Services Inc. ("ISS") and Glass, Lewis & Co. ("Glass...
► Artikel lesen
01.07.Ikena Oncology, Inc. - 8-K, Current Report3
09.06.Ikena Oncology, Inc. - S-4/A, Registration of securities, business combinations1
30.05.Ikena Oncology, Inc. - S-4/A, Registration of securities, business combinations1
20.05.Ikena Oncology, Inc. - S-4/A, Registration of securities, business combinations2
08.05.Ikena Oncology, Inc. - 10-Q, Quarterly Report2
07.05.Ikena Oncology, Inc. - S-4/A, Registration of securities, business combinations4
21.04.Ikena Oncology, Inc. - S-4/A, Registration of securities, business combinations2
18.03.Ikena Oncology, Inc. - S-4, Registration of securities, business combinations4
06.03.Ikena Oncology, Inc. - 10-K, Annual Report-
Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1